微RNA和非酒精性脂肪肝炎:一篇综述
Asahiro Morishita1, Kyoko Oura1, Tomoko Tadokoro1
1Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kita-gun 761-0793, Japan.
International journal of molecular sciences
|October 14, 2023
概括
微RNAs (miRNAs) 是非酒精性脂肪肝炎 (NASH) 的进展中的关键参与者,这是非酒精性脂肪肝疾病 (NAFLD) 的高级形式. 这些分子作为诊断生物标志物和NASH的治疗点具有前景.
科学领域:
- 分子生物学分子生物学
- 肝病学 肝病学是一种肝病学.
- 发现生物标志物的发现.
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 涉及肝细胞中的脂肪积累,可能会发展为非酒精性脂肪性肝炎 (NASH) 严重纤维化.
- 纳什增加了肝脏并发症的风险,如肝细胞癌 (HCC).
- 从NAFLD到NASH的进展是复杂的,涉及诸如肠道微生物群,胆酸,免疫力和遗传因素等因素.
研究的目的:
- 为了识别涉及NASH病变和进展的微RNA (miRNAs).
- 评估这些miRNAs作为NASH的非侵入性生物标志物的潜力.
- 探索特定miRNAs在NASH治疗中的治疗应用.
主要方法:
- 审查和总结现有关于涉及纳氏病的miRNAs的文献.
- 分析特定miRNAs在NASH病理生理学中的作用.
- 评估外体miRNAs作为潜在的诊断和治疗工具.
主要成果:
- 微RNAs (miRNAs) 在NAFLD和NASH的发病过程中具有重要意义.
- 外体miRNA被确定为NASH的潜在敏感和非侵入性生物标志物.
- 特定的miRNA被突出显示为NASH干预的潜在治疗点.
结论:
- 微RNA在NASH的发展和进展中起着至关重要的作用.
- 针对特定的miRNAs为NASH治疗提供了一个有前途的途径.
- 外体miRNAs为早期NASH检测和监测提供了有价值的生物标志物.
相关概念视频
01:22MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
01:24Chronic Pancreatitis I: Introduction
96
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
96
01:26Diseases of the Liver and Gallbladder
589
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
589
01:17Gastritis-II: Pathophysiology
354
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
354